FDA cleared exoskeleton technology

See the following -

ReWalk Featured in VA National Multi-Center Clinical Exoskeleton Trial

Press Release | ReWalk Robotics | February 3, 2016

ReWalk Robotics Ltd...announced that the Department of Veterans Affairs ("VA") has publicly listed details of a national, multi-center study utilizing the Company's Personal 6.0 Exoskeleton Systems. The VA released full details of the study titled, "Exoskeleton Assisted-Walking in Persons With SCI: Impact on Quality of Life" on the clinical trials section of the National Institutes of Health (NIH) website (www.clinicaltrials.gov Identifier: NCT02658656). Several key components of the study outlined by the VA, include...

Read More »

ReWalk Robotics Exoskeleton Deemed Medically Necessary by Independent Medical Review Organization

Press Release | ReWalk Robotics | February 16, 2016

ReWalk Robotics Ltd...announced today that a commercial health plan in the Northwest region of the United States has approved coverage and reimbursement for a ReWalk Personal exoskeleton system, following the ruling of an external independent review organization that overturned the health plan's initial denial of coverage. The beneficiary of the ReWalk device is a surgeon who suffered a spinal cord injury and currently uses a manual custom wheelchair 11 hours a day at work.  Use of the ReWalk will permit the beneficiary to stand up and ambulate both at work and in the home.

Read More »